Amphastar Pharmaceuticals (AMPH) Equity Income (2022 - 2024)
Amphastar Pharmaceuticals (AMPH) posted Equity Income of -$573000.0 for Q1 2024, down 13.47% on a QoQ basis from -$505000.0 in Q4 2023, and up 27.01% year-over-year from -$451158.5 in Q2 2023.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Equity Income (2022 - 2024) Analysis & Trends
Amphastar Pharmaceuticals has reported Equity Income for 3 years, with the latest figure at -$573000.0 in Q1 2024.
- On a quarterly basis, Equity Income rose 27.01% year-over-year to -$573000.0 in Q1 2024; TTM through Dec 2024 was -$573000.0, a 71.08% increase from a year earlier, with the FY2024 full-year figure at -$573000.0, up 71.08% from the prior year.
- Equity Income was -$573000.0 for Q1 2024 at Amphastar Pharmaceuticals, down from -$505000.0 in the prior quarter.
- The five-year high for Equity Income was -$57000.0 in Q4 2022, with the low at -$785000.0 in Q1 2023.
- Average Equity Income over 3 years is -$414555.6, with a median of -$390000.0 recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Equity Income sank 785.96% in 2023, then grew 27.01% in 2024.
- Over 3 years, Equity Income stood at -$57000.0 in 2022, then tumbled by 785.96% to -$505000.0 in 2023, then fell by 13.47% to -$573000.0 in 2024.
- The last three Equity Income figures came in at -$573000.0 (Q1 2024), -$505000.0 (Q4 2023), and -$390000.0 (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -500,000.00 |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -84,502.07 |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | - |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -573,000.00 |
| Dec 31, 2023 | -505,000.00 |
| Sep 30, 2023 | -390,000.00 |
| Jun 30, 2023 | -301,000.00 |
| Mar 31, 2023 | -785,000.00 |
| Dec 31, 2022 | -57,000.00 |
| Sep 30, 2022 | -163,000.00 |
| Jun 30, 2022 | -254,000.00 |
| Mar 31, 2022 | -703,000.00 |